Penumarti Anusha, Abdel-Rahman Abdel A
Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, North Carolina.
Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, North Carolina
J Pharmacol Exp Ther. 2014 Oct;351(1):44-53. doi: 10.1124/jpet.114.216036. Epub 2014 Aug 6.
Direct activation of the endocannabinoid receptor G protein-coupled receptor 18 (GPR18) in the rostral ventrolateral medulla (RVLM) of conscious rats by abnormal cannabidiol (Abn CBD; trans-4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) elevates local nitric oxide (NO) and adiponectin (ADN) levels and reduces oxidative stress and blood pressure (BP). However, the molecular mechanisms for GPR18-mediated neurochemical responses, including the nitric oxide synthase isoform that generates NO, and their potential causal link to the BP reduction are not known. We hypothesized that GPR18-mediated enhancement of Akt, extracellular signal-regulated kinase 1/2 (ERK1/2), and neuronal nitric oxide synthase (nNOS) phosphorylation, triggered by a reduction in cAMP, accounts for the NO/ADN-dependent reductions in RVLM oxidative stress and BP. Intra-RVLM GPR18 activation (Abn CBD; 0.4 μg) enhanced RVLM Akt, ERK1/2, and nNOS phosphorylation as well as ADN levels during the hypotensive response. Prior GPR18 blockade with O-1918 (1,3-dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]benzene) produced the opposite effects and abrogated Abn CBD-evoked neurochemical and BP responses. Pharmacological inhibition of RVLM phosphoinositide 3-kinase (PI3K)/Akt (wortmannin), ERK1/2 (PD98059 [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one]), or nNOS (N(ω)-propyl-l-arginine), or activation of adenylyl cyclase (forskolin) virtually abolished intra-RVLM Abn CBD-evoked hypotension and the increases in Akt, ERK1/2, and nNOS phosphorylation and in ADN levels in the RVLM. Our pharmacological and neurochemical findings support a pivotal role for PI3K, Akt, ERK1/2, nNOS, and adenylyl cyclase, via modulation of NO, ADN, and cAMP levels, in GPR18 regulation of the RVLM redox state and BP in conscious rats.
异常大麻二酚(Abn CBD;反式-4-[3-甲基-6-(1-甲基乙烯基)-2-环己烯-1-基]-5-戊基-1,3-苯二酚)直接激活清醒大鼠延髓头端腹外侧区(RVLM)的内源性大麻素受体G蛋白偶联受体18(GPR18),可提高局部一氧化氮(NO)和脂联素(ADN)水平,并降低氧化应激和血压(BP)。然而,GPR18介导的神经化学反应的分子机制,包括产生NO的一氧化氮合酶同工型,以及它们与血压降低的潜在因果关系尚不清楚。我们假设,由cAMP减少触发的GPR18介导的Akt、细胞外信号调节激酶1/2(ERK1/2)和神经元型一氧化氮合酶(nNOS)磷酸化增强,是RVLM氧化应激和血压依赖于NO/ADN降低的原因。在降压反应期间,RVLM内GPR18激活(Abn CBD;0.4μg)增强了RVLM中Akt、ERK1/2和nNOS的磷酸化以及ADN水平。预先用O-1918(1,3-二甲氧基-5-甲基-2-[(1R,6R)-3-甲基-6-(1-甲基乙烯基)-2-环己烯-1-基]苯)阻断GPR18产生相反的效果,并消除了Abn CBD诱发的神经化学和血压反应。对RVLM磷酸肌醇3激酶(PI3K)/Akt(渥曼青霉素)、ERK1/2(PD98059 [2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮])或nNOS(N(ω)-丙基-L-精氨酸)进行药理学抑制,或激活腺苷酸环化酶(福斯高林),实际上消除了RVLM内Abn CBD诱发的低血压以及RVLM中Akt、ERK1/2和nNOS磷酸化及ADN水平的升高。我们的药理学和神经化学研究结果支持PI3K、Akt、ERK1/2、nNOS和腺苷酸环化酶通过调节NO、ADN和cAMP水平,在清醒大鼠GPR18对RVLM氧化还原状态和血压的调节中起关键作用。